Diversity, Inclusion, and Community Engagement

You know the challenge: Age, genetics, gender, and a multitude of other characteristics — physical, mental, lifestyle, and otherwise — can lead people to experience vastly different responses to the same therapy. To bring equitable products to market, clinical trials need proportionate representation.

We believe diversity must be prioritized at the site level, where clinical research is most visible in communities.

Sites act as the frontline of clinical research, making their role in representing, understanding, and engaging diverse communities vital.

Therefore, Velocity is heavily invested in leveraging local influence to drive change. Our focus is on managing what we can effectively control at the site level to foster a more inclusive and representative clinical trial landscape.

Driving Inclusive Trials

A recent study has shown that clinical trial sites with diverse personnel are better equipped to recruit volunteers from racial and ethnic minority groups. This highlights the importance of diversity, not only in the participant population, but also in the clinical research workforce.

Building trust and engagement with patients is key to increasing clinical trial recruitment, participation, and completion rates. To do so, Velocity invests in diversity, equity, and inclusion (DEI) initiatives that strengthen employee awareness, study conduct, and the clinical research community as a whole.

U.S. Department of Health and Human Services (HHS) Officials Meet With Leaders to Discuss COVID-19 Vaccine Clinical Trials and Patient Recruitment
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
caring african medical nurse comforting senior patient in office
investigator-patient
clinical research site team

Diversity at Velocity Clinical Research

Ensuring Employee Diversity

About half of Velocity’s workforce identifies as non-white

Making Sites Accessible

Establishing sites in demographically diverse, easily accessible locations

Removing Language Barriers

Employing bilingual staff, utilizing real-time translation, and offering materials tailored for minority groups

Engaging Communities

Establishing partnerships with local groups, appointing community liaisons, and initiating charitable programs

Intensive Data Capture

Capturing full race and ethnicity data for all database patients

Ongoing Staff Training

Promoting an inclusive culture, minimizing bias, and maintaining a safe, unbiased environment

Accessible Technology

Using technology to improve the way people find and participate in clinical trials

Focusing on Patients

2023 SCRS Patient Centricity Award Winner for innovative programs

Featured Initiative

Real-time interpreting for 300+ languages

Velocity is committed to inclusivity and ensuring that everyone, regardless of their nationality or spoken language, can participate in groundbreaking clinical research studies.

Language should never be a barrier to advancing medicine, and so, in collaboration with Boostlingo, we offer live phone and video interpretation services in over 300 languages. This includes Spanish, French, Arabic, Russian, German, Portuguese, Hindi, Mandarin, Japanese, and many more. A standout success of this solution was Velocity’s enrollment of its first participant using American Sign Language (ASL).

With this extensive language support, we aim to create a welcoming and accessible environment for individuals from diverse linguistic backgrounds. Velocity can support immediate interpretation services, or schedule services ahead of time to ensure fast and accurate communication through each step of the clinical research process.

Language-Support
ACRP Ride4DEI

Featured Initiative

The ACRP Ride4DEI

Providing scholarships for professional growth and development for clinical researchers of diverse backgrounds, the Association of Clinical Research Professionals (ACRP) Ride4DEI is a cycling challenge created by Sergio Armani, EVP, Business Development, Helios Clinical Research, and Rick Fisher, VP, Operations, Velocity Clinical Research.

Starting in 2021, Sergio and Rick teamed up to complete this grueling journey through the mountains and the mud, venturing from Pittsburgh, PA, to Washington, DC, to raise funds to improve diversity and inclusion in the clinical research workforce. Over the past couple years, the number of cyclists and the amounts raised have grown tremendously, providing ACRP educational scholarships — including attendance at the ACRP’s annual conference — for entry-level clinical research professionals from diverse communities.

A proud sponsor of this year’s challenge, Velocity is committed to improving health equity in clinical trials — for participants, researchers, and site staff alike. To support the ACRP Ride4DEI, visit this website. You can also join the conversation on social media — share a photo of you going for a ride or share some encouraging words for the riders with #Ride4DEI to help others learn about this fundraiser.

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

Improving Representation in Trials

Supporting your diversity goals

In April 2022, FDA released draft guidance regarding “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.” This draft guidance outlines recommendations on developing and executing plans aimed at increasing clinical trial participation in historically underrepresented populations.

Given Velocity’s unique recruitment capabilities and scale, we are increasingly supporting Sponsors and CROs in strategically aligning diversity and inclusion goals. Velocity presents sites in locations that support representative diversity.

Join a remarkable team doing remarkable work

Through inclusive hiring initiatives, Velocity strives to ensure its workforce comprises various minority groups. Velocity’s site staff are representative of the communities they serve in ethnicity, gender, race, and even languages spoken.

Velocity’s site staff are also empowered to support local community groups to foster relationships with underserved communities, especially communities of color and the LGBTQ community. Velocity staff frequently sponsors, attends, and exhibits at local community events, connects with local community leaders, and supports nonprofits and charities.

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities. Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Site Representative in Office

Let's talk about your next trial

Quality. Continuity. Velocity.